Keeler Thomas Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Keeler Thomas Management's RGEN Position: Q2 2025 in Review
Keeler Thomas Management sold out of Repligen (RGEN) in Q2 2025, closing a stake of 4,879 shares — an estimated $621K sold.
Keeler Thomas Management first reported a position in RGEN in Q3 2023 and held it in 4 quarters. The position peaked at $1.29M in Q4 2024. 443 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.
- Keeler Thomas Management reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
- Keeler Thomas Management sold 4,879 Repligen shares in Q2 2025, an estimated $621K.
- Keeler Thomas Management first reported a position in Repligen in Q3 2023 and held it in 4 quarters.
- Keeler Thomas Management's Repligen position peaked at $1.29M in Q4 2024.
- 443 funds tracked by Wall St. Rank held Repligen as of Q2 2025.
Based on Keeler Thomas Management's 13F filing for Q2 2025, filed 31 Jul 2025.